Obicetrapib excels as lipid lowering agent in Phase 3 trials Dr. Shravani Dali12 May 2025 9:00 AM ISTObicetrapib, a highly selective oral CETP inhibitor, has shown significant promise in a Phase III trial by dramatically reducing LDL cholesterol...
Brensocatib Significantly Reduces Exacerbations in Bronchiectasis, confirms study Dr Riya Dave5 May 2025 8:45 PM ISTResearchers have discovered in a new study that treating airway inflammation with the experimental drug brensocatib lowers the rate of pulmonary...
Medical Bulletin 05/ May/ 2025 Dr. Garima Soni5 May 2025 3:00 PM ISTHere are the top medical news for the day:Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the...
Could a Popular Weight Loss Drug Help Treat Fatty Liver? Study Sheds Light Dr. Garima Soni5 May 2025 8:15 AM ISTA new phase 3 clinical trial published this week in The New England Journal of Medicine concludes that semaglutide, a widely used diabetes medication,...
Single dose of baloxavir lowers the risk of influenza virus transmission to close contacts: NEJM Jacinthlyn Sylvia29 April 2025 9:15 AM ISTA new study published in The New England Journal of Medicine showed that a single dosage of the antiviral baloxavir marboxil (Xofluza) reduced the...
Sotatercept may Reduce all-cause mortality in pulmonary arterial hypertension patients, finds research Jacinthlyn Sylvia20 April 2025 8:15 PM ISTA new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial hypertension (PAH), adding...
Routine use of cerebral emboli prevention devices during TAVI fails to reduce stroke incidence: NEJM Jacinthlyn Sylvia8 April 2025 8:30 AM ISTA new study published in The New England Journal of Medicine showed that stroke was not prevented by routinely using devices to avoid cerebral emboli...
Oral Infigratinib Improves Growth in Children with Achondroplasia, finds NEJM study Dr Riya Dave27 March 2025 9:30 PM ISTResearchers have identified in a new study that oral infigratinib, an FGFR1-3 selective tyrosine kinase inhibitor, improves annualized height velocity...
Antimicrobial therapy for both partners found effective for women with bacterial vaginosis: NEJM Jacinthlyn Sylvia13 March 2025 8:30 PM ISTA new study published in The New England Journal of Medicine revealed that in addition to treating female patients, treating male companions with...
Bedaquiline monotherapy may improve skin lesions in multibacillary leprosy patients, suggests study Jacinthlyn Sylvia12 March 2025 6:15 AM ISTA new study published in The New England Journal of Medicine showed that by 4 weeks of treatment, bedaquiline monotherapy eliminated Mycobacterium...
No significant benefit of Levofloxacin in Prevention of MDR Tuberculosis in Children, finds study Dr Riya Dave5 March 2025 8:45 PM ISTResearchers have identified that preventive therapy with levofloxacin led to a reduced incidence of tuberculosis over placebo in children with...
Abelacimab reduces ischemic Stroke Risk in Atrial Fibrillation Patients with fewer bleeding events: NEJM Dr Riya Dave31 Jan 2025 8:00 AM ISTResearchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for stroke, administration of...
